Literature DB >> 9840597

Schistosomiasis of the lower reproductive tract without egg excretion in urine.

G Poggensee1, I Kiwelu, M Saria, J Richter, I Krantz, H Feldmeier.   

Abstract

The individual and public health impact of female genital schistosomiasis (FGS) has been studied and FGS as a risk factor for acquiring human immunodeficiency virus is discussed. In a community-based study in Tanzania, 40% of the women of child-bearing age (n=543) showed excretion of Schistosoma haematobium eggs in the urine (median=2.2 eggs/10 ml of urine) and 32% (n=263) had S. haematobium eggs in their cervical tissue. Urinary and genital schistosomiasis coexisted in 62% of the women, but S. haematobium eggs were found in the cervix without detectable egg excretion in the urine in 23%. Only 43% of the FGS cases had hematuria. Since FGS frequently exists in women with scanty or no egg excretion in the urine and because this disease manifestation is a considerable individual and public health hazard in S. haematobium-endemic areas, mass treatment targeted to women of child-bearing age should be considered.

Entities:  

Mesh:

Year:  1998        PMID: 9840597     DOI: 10.4269/ajtmh.1998.59.782

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  27 in total

Review 1.  Circulating antigen tests and urine reagent strips for diagnosis of active schistosomiasis in endemic areas.

Authors:  Eleanor A Ochodo; Gowri Gopalakrishna; Bea Spek; Johannes B Reitsma; Lisette van Lieshout; Katja Polman; Poppy Lamberton; Patrick M M Bossuyt; Mariska M G Leeflang
Journal:  Cochrane Database Syst Rev       Date:  2015-03-11

2.  Considering treatment of male genital schistosomiasis as a tool for future HIV prevention: a systematic review.

Authors:  Chalotte Willemann Stecher; Per Kallestrup; Eyrun Floerecke Kjetland; Birgitte Vennervald; Eskild Petersen
Journal:  Int J Public Health       Date:  2015-08-23       Impact factor: 3.380

3.  A survey of female genital schistosomiasis of the lower reproductive tract in the volta basin of Ghana.

Authors:  D Yirenya-Tawiah; C Amoah; K A Apea-Kubi; M Dade; M Ackumey; T Annang; D Y Mensah; K M Bosompem
Journal:  Ghana Med J       Date:  2011-03

4.  Placental Schistosoma haematobium infection in a German returnee from Malawi.

Authors:  B T Schleenvoigt; M Gajda; M Baier; T Groten; H Oppel-Heuchel; M O Grimm; W Pfister; J Richter; M W Pletz
Journal:  Infection       Date:  2014-09-19       Impact factor: 3.553

Review 5.  Schistosomiasis--an unusual cause of ureteral obstruction: a case history and perspective.

Authors:  Peter M Neal
Journal:  Clin Med Res       Date:  2004-11

6.  The WHO ultrasonography protocol for assessing morbidity due to Schistosoma haematobium. Acceptance and evolution over 14 years. Systematic review.

Authors:  Robert Akpata; Andreas Neumayr; Martha C Holtfreter; Ingela Krantz; Daman D Singh; Rodrigo Mota; Susanne Walter; Christoph Hatz; Joachim Richter
Journal:  Parasitol Res       Date:  2015-02-25       Impact factor: 2.289

7.  Detecting Schistosoma haematobium infection by microscopy and polymerase chain reaction (PCR) in school children in three senatorial districts of Cross River State, Nigeria.

Authors:  Rosemary Kaiso Esiere; Emmanuel Onyekachukwu Ibeneme; Emmanuel Offiong Effanga; Edema Enogiomwan Imalele; Miracle Kaiso Esiere; Paul Columba Inyang-Etoh; Ambrose Andrew Anyanwu Alaribe
Journal:  J Parasit Dis       Date:  2021-09-02

8.  Surgical pathology of schistosomiasis.

Authors:  Aminu Z Mohammed; Steven T Edino; Adamu A Samaila
Journal:  J Natl Med Assoc       Date:  2007-05       Impact factor: 1.798

9.  Halting Schistosoma haematobium - associated bladder cancer.

Authors:  Monica C Botelho; Helena Alves; Joachim Richter
Journal:  Int J Cancer Manag       Date:  2017-09-30

10.  Association between cervical dysplasia and female genital schistosomiasis diagnosed by genital PCR in Zambian women.

Authors:  H Rafferty; A S Sturt; C R Phiri; E L Webb; M Mudenda; J Mapani; P L A M Corstjens; G J van Dam; A Schaap; H Ayles; R J Hayes; L van Lieshout; I Hansingo; A L Bustinduy
Journal:  BMC Infect Dis       Date:  2021-07-17       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.